![]() 前立腺の健康市場Prostate Health Market Future Market Insights社が発行したこの市場に関する最新調査では、2014年から2021年までの世界の産業分析と2022年から2032年までの機会評価を提供しています。この調査は、より重要な市場力学の包括的な評価を... もっと見る
![]()
サマリーFuture Market Insights社が発行したこの市場に関する最新調査では、2014年から2021年までの世界の産業分析と2022年から2032年までの機会評価を提供しています。この調査は、より重要な市場力学の包括的な評価を提供しています。前立腺健康市場の過去と現在の成長パラメータを徹底的に調査した後、市場の成長見通しを最大限の精度で得ることができます。 市場区分 本書は、市場のあらゆる側面をカバーし、読者に完全な市場情報を提供するため、詳細にセグメント化されています。 疾患別適応症 前立腺癌 前立腺肥大症(Benign Prostate Hyperplasia 前 立腺炎 地域別 北アメリカ ラテンアメリカ ヨーロッパ アジア太平洋地域 中近東・アフリカ 報告書の章立て 第01章 - エグゼクティブサマリー 前立腺健康市場に関するエグゼクティブサマリーには、市場独自の輪切り、需要側と供給側の動向、機会評価、前立腺健康市場に関する提言が含まれています。 第02章 市場の概要 読者はこの章で前立腺健康市場の詳細なセグメンテーションと定義を知ることができ、前立腺健康市場の基本的な情報を理解することができます。また、この章では、読者が前立腺ヘルスの市場範囲を理解するのに役立つ、包含と除外を強調します。 第03章 市場の背景 このセクションでは、前立腺の健康市場の関連産業評価を実施します。前立腺健康市場の成長に影響を与えるマクロ経済的要因を提供し、これらのマクロ経済指標が前立腺健康市場に与える影響を分析します。前立腺健康市場における処理の概要と技術的進歩も提供します。 第04章 前立腺ヘルスの市場バリューチェーン 前立腺疾患市場の各レベルにおける利益率を分析し、読者は上位輸入業者と輸出業者、および前立腺疾患市場のバリューチェーンに関する詳細情報を得ることができます。 第05章 市場ダイナミクス 本章では、前立腺ヘルスの市場成長に影響を与えるドライバーと阻害要因について説明します。前立腺ヘルスの市場における機会や進行中のトレンドについても包括的に考察しています。 第06章 前立腺ヘルスの市場-価格分析 この章では、製品タイプ別に世界および地域の価格分析を行います。また、価格設定に影響を与える要因についても解説しています。2022年、2032年におけるメーカーレベル、販売店レベル、小売レベルの価格分析がご覧いただけます。 第07章 前立腺の健康市場の需要分析と予測 2022-2032年 本章では、過去の前立腺健康市場(2014年~2021年)の詳細な分析に加え、予測期間(2022年~2032年)の機会分析も行います。読者は、今年度(2022年)の絶対的な$の機会と予測期間(2022-2032年)の増分的な機会も見つけることができます。 第8章 前立腺ヘルスの世界市場分析(2014年~2021年)&機会評価(2022年~2032年) 前立腺ヘルスの市場は、ロボットの種類によって、多関節型、直交型、円筒型、極型、スカラ型、デルタ型に分類されます。本章では、読者は前立腺健康市場における主要なトレンドと開発に関する情報、およびロボットタイプに基づく市場の魅力的な分析をご覧いただけます。 第9章 前立腺ヘルスの世界市場分析(2014年~2021年)&機会評価(2022年~2032年) ロボットシステムの種類に基づき、前立腺ヘルスの市場はマニピュレーションロボットシステム、モバイルロボットシステム、データ収集・制御ロボットシステムに区分されます。本章では、読者は前立腺健康市場の主要トレンドと開発に関する情報、およびロボットシステムタイプに基づく市場の魅力的な分析をご覧いただけます。 第10章 前立腺ヘルスの世界市場分析(2014年~2021年)&機会評価(2022年~2032年) 前立腺ヘルスの市場は用途により、産業用ロボット、医療用ロボット、消費者用ロボットに区分されます。本章では、読者は前立腺健康市場における主要なトレンドと開発、アプリケーションに基づく市場の魅力的な分析に関する情報を得ることができます。 第11章 前立腺ヘルスの世界市場分析(2014年~2021年)&機会評価(2022年~2032年) 前立腺ヘルスの市場は、提供方法によって標準品とカスタマイズ品に分類されます。本章では、読者は前立腺健康市場の主要な動向と発展に関する情報、およびオファリングに基づく市場の魅力的な分析をご覧いただくことができます。 第12章 前立腺ヘルスの世界市場分析(2014年~2021年)&機会評価(2022年~2032年) 前立腺ヘルスの市場は、ソフトウェアに基づいて、ピック&プレース、ドリル、ホールド&ローテート、塗装、打撃、パンチング&ブランキング、溶接、検査、切断、レイアウト、マーキング&計測、研削&研磨、その他に分類されます。この章では、読者が前立腺健康市場の主要な動向と発展、ソフトウェアに基づく市場の魅力的な分析に関する情報を得ることができます。 第13章 前立腺ヘルスの世界市場分析(2014年~2021年)&機会評価(2022年~2032年) 前立腺ヘルスの市場は、モーションタイプにより、リニア、ロータリー、オシレート、全方位に区分されます。本章では、前立腺ヘルスの主要トレンドと開発に関する情報、モーションタイプに基づく市場の魅力的な分析について紹介します。 第14章 前立腺ヘルスの世界市場分析(2014年~2021年)&機会評価(2022年~2032年) 前立腺ヘルスの市場は、最終用途に基づき、製造業、石油・ガス、ヘルスケア、研究アカデミア、その他に区分されます。本章では、読者が前立腺健康市場の主要な動向と発展、および最終用途に基づく市場の魅力的な分析に関する情報を得ることができます。 第15章 前立腺ヘルスの世界市場分析(2014年~2021年)&機会評価(2022年~2032年) 本章では、北米、中南米、西ヨーロッパ、東ヨーロッパ、東南アジア&太平洋、中国、インド、日本、中東&アフリカ(MEA)など、さまざまな地域にわたって前立腺ヘルスの市場がどのように成長するのかを解説します。 第16章 北米前立腺ヘルスの市場分析 2014-2021年&機会評価 2022-2032年 本章では、北米の前立腺疾患市場の成長について、米国やカナダなど国別の評価とともに詳細に分析します。また、北米におけるロボットタイプ、ロボットシステムタイプ、アプリケーション、オファリング、ソフトウェア、モーションタイプ、エンドユース、ロボットにおけるモーションコントロールソフトウェアの国別に地域動向と市場成長をご覧いただけます。 第17章 ラテンアメリカの前立腺健康市場分析2014-2021年&機会評価2022-2032年 読者は、中南米前立腺健康市場の成長に影響を与える要因、価格分析、地域動向などの詳細な情報を得ることができます。本章では、ブラジル、メキシコ、その他のラテンアメリカ地域など、ラテンアメリカの主要国における前立腺健康市場の成長展望も記載しています。 第18章 東欧の前立腺ヘルスの市場分析 2014-2021年&予測 2022-2032年 本章では、ポーランド、チェコ、その他の東欧諸国を含む国別の評価とともに、東欧の前立腺疾患市場の成長について詳しく分析します。読者は、東欧の国々に基づく価格分析、地域動向、市場成長もご覧いただけます。 第19章 西ヨーロッパ前立腺ヘルスの市場分析 2014-2021年&予測 2022-2032年 本章では、西欧の前立腺疾患市場の成長について、イギリス、フランス、ドイツ、その他の西欧諸国を含む国別の評価とともに詳細に分析します。読者は、西ヨーロッパの国々に基づく価格分析、地域動向、市場成長もご覧いただけます。 第20章 APEJ前立腺ヘルスの市場分析 2014-2021年&機会評価 2022-2032年 読者は、2022年から2032年までのAPEJ前立腺健康市場の成長パラメータに関する徹底的な情報を得ることができます。 第21章 日本前立腺医療市場分析 2014-2021年&機会評価 2022-2032年 読者は、市場セグメンテーションに基づき、予測期間中に日本における前立腺健康市場の成長に大きな影響を与える重要な要因を見つけることができます。本章では、日本の前立腺疾患市場の促進要因、阻害要因、トレンドの概要を説明します。 第22章 MEA前立腺健康市場分析 2014-2021年&機会評価 2022-2032年 本章では、2022年から2032年の間に、GCC諸国、南アフリカ、その他のMEA地域などのMEA地域の主要国で前立腺健康市場がどのように成長するのかについての情報を提供します。 第23章 競争環境、企業シェア、企業プロファイル 本章では、前立腺健康市場における主要なステークホルダーを網羅的にリストアップするとともに、各企業に関する詳細情報(企業概要、売上シェア、戦略的概要、最近の企業動向など)を掲載しています。 第24章 前提条件と頭字語 この章では、レポートに含まれる情報や統計の根拠となる略語や仮定をリストアップしています。 第25章 調査方法 本章では、前立腺健康市場に関する様々な結論、重要な定性情報、定量情報を得るために行った調査方法について読者の理解を助ける。 目次1. Executive Summary1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. Fact.MR Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Prostate Health Demand 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Mn) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background and Foundation Data Points 4.1. Global Prostate Health Market (US$ Mn) 4.2. Prostate Health Market Opportunity Assessment (US$ Mn) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Global Prostate Health Market Growth 4.5.3. Prostate Health Adoption Rate, by Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Prostate Health Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global Prostate Health Market Demand Analysis 2015-2021 and Forecast, 2022-2032 6.1. Historical Market Analysis, 2015-2021 6.2. Current and Future Market Projections, 2022-2032 6.3. Y-o-Y Growth Trend Analysis 7. Global Prostate Health Market Value Analysis 2015-2021 and Forecast, 2022-2032 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032, By Disease Indication 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Disease Indication, 2015-2021 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Indication, 2022-2032 8.3.1. Prostate Cancer 8.3.1.1. AR Directed Therapies 8.3.1.2. Hormone ADT 8.3.1.3. Cytotoxic Agents 8.3.1.4. PARP Inhibitors 8.3.1.5. Others 8.3.2. Benign Prostate Hyperplasia 8.3.2.1. Alpha Blockers 8.3.2.1.1. Alfuzosin 8.3.2.1.2. Doxazosin 8.3.2.1.3. Tamsulosin 8.3.2.1.4. Silodosin 8.3.2.1.5. Other Alpha Blockers 8.3.2.2. 5 Alpha Reductase 8.3.2.2.1. Finasteride 8.3.2.2.2. Dutasteride 8.3.2.3. Others 8.3.3. Prostatitis 8.3.3.1. Prescription 8.3.3.2. Over the Counter 8.4. Market Attractiveness Analysis By Disease Indication 9. Global Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032, By Region 9.1. Introduction 9.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021 9.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. Asia Pacific 9.3.5. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032 10.1. Introduction 10.2. Pricing Analysis 10.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 10.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 10.4.1. By Country 10.4.1.1. U.S. 10.4.1.2. Canada 10.4.2. By Disease Indication 10.5. Market Attractiveness Analysis 10.5.1. By Country 10.5.2. By Disease Indication 11. Latin America Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032 11.1. Introduction 11.2. Pricing Analysis 11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 11.4.1. By Country 11.4.1.1. Brazil 11.4.1.2. Mexico 11.4.1.3. Rest of Latin America 11.4.2. By Disease Indication 11.5. Market Attractiveness Analysis 11.5.1. By Country 11.5.2. By Disease Indication 12. Europe Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 12.4.1. By Country 12.4.1.1. Germany 12.4.1.2. France 12.4.1.3. U.K. 12.4.1.4. Italy 12.4.1.5. Benelux 12.4.1.6. Nordic Countries 12.4.1.7. Rest of Europe 12.4.2. By Disease Indication 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Disease Indication 13. Asia Pacific Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 13.4.1. By Country 13.4.1.1. China 13.4.1.2. Japan 13.4.1.3. South Korea 13.4.1.4. Rest of Asia Pacific 13.4.2. By Disease Indication 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Disease Indication 14. Middle East and Africa Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 14.4.1. By Country 14.4.1.1. GCC Countries 14.4.1.2. South Africa 14.4.1.3. Turkey 14.4.1.4. Rest of Middle East and Africa 14.4.2. By Disease Indication 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Disease Indication 15. Key Countries Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032 15.1. Introduction 15.1.1. Market Value Proportion Analysis, By Key Countries 15.1.2. Global Vs. Country Growth Comparison 15.2. US Prostate Health Market Analysis 15.2.1. Value Proportion Analysis by Market Taxonomy 15.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.2.2.1. By Disease Indication 15.3. Canada Prostate Health Market Analysis 15.3.1. Value Proportion Analysis by Market Taxonomy 15.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.3.2.1. By Disease Indication 15.4. Mexico Prostate Health Market Analysis 15.4.1. Value Proportion Analysis by Market Taxonomy 15.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.4.2.1. By Disease Indication 15.5. Brazil Prostate Health Market Analysis 15.5.1. Value Proportion Analysis by Market Taxonomy 15.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.5.2.1. By Disease Indication 15.6. Germany Prostate Health Market Analysis 15.6.1. Value Proportion Analysis by Market Taxonomy 15.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.6.2.1. By Disease Indication 15.7. France Prostate Health Market Analysis 15.7.1. Value Proportion Analysis by Market Taxonomy 15.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.7.2.1. By Disease Indication 15.8. Italy Prostate Health Market Analysis 15.8.1. Value Proportion Analysis by Market Taxonomy 15.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.8.2.1. By Disease Indication 15.9. BENELUX Prostate Health Market Analysis 15.9.1. Value Proportion Analysis by Market Taxonomy 15.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.9.2.1. By Disease Indication 15.10. UK Prostate Health Market Analysis 15.10.1. Value Proportion Analysis by Market Taxonomy 15.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.10.2.1. By Disease Indication 15.11. Nordic Countries Prostate Health Market Analysis 15.11.1. Value Proportion Analysis by Market Taxonomy 15.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.11.2.1. By Disease Indication 15.12. China Prostate Health Market Analysis 15.12.1. Value Proportion Analysis by Market Taxonomy 15.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.12.2.1. By Disease Indication 15.13. Japan Prostate Health Market Analysis 15.13.1. Value Proportion Analysis by Market Taxonomy 15.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.13.2.1. By Disease Indication 15.14. South Korea Prostate Health Market Analysis 15.14.1. Value Proportion Analysis by Market Taxonomy 15.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.14.2.1. By Disease Indication 15.15. GCC Countries Prostate Health Market Analysis 15.15.1. Value Proportion Analysis by Market Taxonomy 15.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.15.2.1. By Disease Indication 15.16. South Africa Prostate Health Market Analysis 15.16.1. Value Proportion Analysis by Market Taxonomy 15.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.16.2.1. By Disease Indication 15.17. Turkey Prostate Health Market Analysis 15.17.1. Value Proportion Analysis by Market Taxonomy 15.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.17.2.1. By Disease Indication 15.17.3. Competition Landscape and Player Concentration in the Country 16. Market Structure Analysis 16.1. Market Analysis by Tier of Companies 16.2. Market Concentration 16.3. Market Share Analysis of Top Players 16.4. Market Presence Analysis 16.4.1. By Regional footprint of Players 16.4.2. Product footprint by Players 17. Competition Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Competition Deep Dive 17.3.1. GLAXOSMITHKLINE 17.3.1.1. Overview 17.3.1.2. Product Portfolio 17.3.1.3. Sales Footprint 17.3.1.4. Strategy Overview 17.3.2. ASTELLAS PHARMA 17.3.2.1. Overview 17.3.2.2. Product Portfolio 17.3.2.3. Sales Footprint 17.3.2.4. Strategy Overview 17.3.3. ALLERGAN 17.3.3.1. Overview 17.3.3.2. Product Portfolio 17.3.3.3. Sales Footprint 17.3.3.4. Strategy Overview 17.3.4. MERCK 17.3.4.1. Overview 17.3.4.2. Product Portfolio 17.3.4.3. Sales Footprint 17.3.4.4. Strategy Overview 17.3.5. ELI LILLY AND COMPANY 17.3.5.1. Overview 17.3.5.2. Product Portfolio 17.3.5.3. Sales Footprint 17.3.5.4. Strategy Overview 17.3.6. ABBOTT LABORATORIES 17.3.6.1. Overview 17.3.6.2. Product Portfolio 17.3.6.3. Sales Footprint 17.3.6.4. Strategy Overview 17.3.7. JOHNSON & JOHNSON SERVICES, INC. 17.3.7.1. Overview 17.3.7.2. Product Portfolio 17.3.7.3. Sales Footprint 17.3.7.4. Strategy Overview 17.3.8. ABBVIE 17.3.8.1. Overview 17.3.8.2. Product Portfolio 17.3.8.3. Sales Footprint 17.3.8.4. Strategy Overview 17.3.9. SANOFI 17.3.9.1. Overview 17.3.9.2. Product Portfolio 17.3.9.3. Sales Footprint 17.3.9.4. Strategy Overview 17.3.10. PFIZER, INC. 17.3.10.1. Overview 17.3.10.2. Product Portfolio 17.3.10.3. Sales Footprint 17.3.10.4. Strategy Overview 18. Assumptions and Acronyms Used 19. Research Methodology Table 1: Global Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021 Table 2: Global Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032 Table 3: Global Prostate Health Market, By Region, 2015 – 2021 Table 4: Global Prostate Health Market, By Region, 2022 – 2032 Table 5: North America Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021 Table 6: North America Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032 Table 7: North America Prostate Health Market, By Country, 2015 – 2021 Table 8: North America Prostate Health Market, By Country, 2022 – 2032 Table 9: Latin America Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021 Table 10: Latin America Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032 Table 11: Latin America Prostate Health Market, By Country, 2015 – 2021 Table 12: Latin America Prostate Health Market, By Country, 2022 – 2032 Table 13: Europe Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021 Table 14: Europe Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032 Table 15: Europe Prostate Health Market, By Country, 2015 – 2021 Table 16: Europe Prostate Health Market, By Country, 2022 – 2032 Table 17: Asia Pacific Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021 Table 18: Asia Pacific Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032 Table 19: Asia Pacific Prostate Health Market, By Country, 2015 – 2021 Table 20: Asia Pacific Prostate Health Market, By Country, 2022 – 2032 Table 21: MEA Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021 Table 22: MEA Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032 Table 23: MEA Prostate Health Market, By Country, 2015 – 2021 Table 24: MEA Prostate Health Market, By Country, 2022 – 2032 Table 25: Global Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021 Table 26: Global Prostate Health Market Incremental $ Opportunity, By Region, 2022 – 2032 Table 27: North America Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021 Table 28: North America Prostate Health Market Incremental $ Opportunity, By Country, 2022 – 2032 Table 29: Latin America Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021 Table 30: Latin America Prostate Health Market Incremental $ Opportunity, By Country, 2022 – 2032 Table 31: Europe Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021 Table 32: Europe Prostate Health Market Incremental $ Opportunity, By Country, 2022 - 2032 Table 33: Asia Pacific Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021 Table 34: Asia Pacific Prostate Health Market Incremental $ Opportunity, By Country, 2022 – 2032 Table 35: MEA Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021 Table 36: MEA Prostate Health Market Incremental $ Opportunity, By Country, 2022 - 2032 Figure 1: Global Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032 Figure 2: Global Prostate Health Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn Figure 3: Global Prostate Health Market Share, By Disease Indication, 2022 & 2032 Figure 4: Global Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032 Figure 5: Global Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032 Figure 6: Global Prostate Health Market Share, By Region, 2022 & 2032 Figure 7: Global Prostate Health Market Y-o-Y Growth Projections, By Region – 2022-2032 Figure 8: Global Prostate Health Market Attractiveness Index, By Region – 2022-2032 Figure 9: North America Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032 Figure 10: North America Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn Figure 11: North America Prostate Health Market Share, By Disease Indication, 2022 & 2032 Figure 12: North America Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032 Figure 13: North America Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032 Figure 14: North America Prostate Health Market Share, By Country, 2022 & 2032 Figure 15: North America Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032 Figure 16: North America Prostate Health Market Attractiveness Index, By Country – 2022-2032 Figure 17: Latin America Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032 Figure 18: Latin America Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn Figure 19: Latin America Prostate Health Market Share, By Disease Indication, 2022 & 2032 Figure 20: Latin America Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032 Figure 21: Latin America Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032 Figure 22: Latin America Prostate Health Market Share, By Country, 2022 & 2032 Figure 23: Latin America Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032 Figure 24: Latin America Prostate Health Market Attractiveness Index, By Country – 2022-2032 Figure 25: Europe Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032 Figure 26: Europe Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn Figure 27: Europe Prostate Health Market Share, By Disease Indication, 2022 & 2032 Figure 28: Europe Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032 Figure 29: Europe Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032 Figure 30: Europe Prostate Health Market Share, By Country, 2022 & 2032 Figure 31: Europe Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032 Figure 32: Europe Prostate Health Market Attractiveness Index, By Country – 2022-2032 Figure 33: MEA Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032 Figure 34: MEA Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn Figure 35: MEA Prostate Health Market Share, By Disease Indication, 2022 & 2032 Figure 36: MEA Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032 Figure 37: MEA Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032 Figure 38: MEA Prostate Health Market Share, By Country, 2022 & 2032 Figure 39: MEA Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032 Figure 40: MEA Prostate Health Market Attractiveness Index, By Country – 2022-2032 Figure 41: Asia Pacific Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032 Figure 42: Asia Pacific Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn Figure 43: Asia Pacific Prostate Health Market Share, By Disease Indication, 2022 & 2032 Figure 44: Asia Pacific Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032 Figure 45: Asia Pacific Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032 Figure 46: Asia Pacific Prostate Health Market Share, By Country, 2022 & 2032 Figure 47: Asia Pacific Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032 Figure 48: Asia Pacific Prostate Health Market Attractiveness Index, By Country – 2022-2032 Figure 49: US Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 50: US Prostate Health Market Share, By Disease Indication, 2021 Figure 51: Canada Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 52: Canada Prostate Health Market Share, By Disease Indication, 2021 Figure 53: Brazil Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 54: Brazil Prostate Health Market Share, By Disease Indication, 2021 Figure 55: Mexico Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 56: Mexico Prostate Health Market Share, By Disease Indication, 2021 Figure 57: Germany Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 58: Germany Prostate Health Market Share, By Disease Indication, 2021 Figure 59: U.K. Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 60: U.K. Prostate Health Market Share, By Disease Indication, 2021 Figure 61: France Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 62: France Prostate Health Market Share, By Disease Indication, 2021 Figure 63: Italy Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 64: Italy Prostate Health Market Share, By Disease Indication, 2021 Figure 65: BENELUX Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 66: BENELUX Prostate Health Market Share, By Disease Indication, 2021 Figure 67: Nordic Countries Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 68: Nordic Countries Prostate Health Market Share, By Disease Indication, 2021 Figure 69: China Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 70: China Prostate Health Market Share, By Disease Indication, 2021 Figure 71: Japan Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 72: Japan Prostate Health Market Share, By Disease Indication, 2021 Figure 73: South Korea Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 74: South Korea Prostate Health Market Share, By Disease Indication, 2021 Figure 75: GCC Countries Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 76: GCC Countries Prostate Health Market Share, By Disease Indication, 2021 Figure 77: South Africa Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 78: South Africa Prostate Health Market Share, By Disease Indication, 2021 Figure 79: Turkey Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 80: Turkey Prostate Health Market Share, By Disease Indication, 2021
SummaryA recent market study published by Future Market Insights on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022–2032. The study offers a comprehensive assessment of the more important market dynamics. Table of Contents1. Executive Summary1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. Fact.MR Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Prostate Health Demand 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Mn) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background and Foundation Data Points 4.1. Global Prostate Health Market (US$ Mn) 4.2. Prostate Health Market Opportunity Assessment (US$ Mn) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Global Prostate Health Market Growth 4.5.3. Prostate Health Adoption Rate, by Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Prostate Health Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global Prostate Health Market Demand Analysis 2015-2021 and Forecast, 2022-2032 6.1. Historical Market Analysis, 2015-2021 6.2. Current and Future Market Projections, 2022-2032 6.3. Y-o-Y Growth Trend Analysis 7. Global Prostate Health Market Value Analysis 2015-2021 and Forecast, 2022-2032 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032, By Disease Indication 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Disease Indication, 2015-2021 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Indication, 2022-2032 8.3.1. Prostate Cancer 8.3.1.1. AR Directed Therapies 8.3.1.2. Hormone ADT 8.3.1.3. Cytotoxic Agents 8.3.1.4. PARP Inhibitors 8.3.1.5. Others 8.3.2. Benign Prostate Hyperplasia 8.3.2.1. Alpha Blockers 8.3.2.1.1. Alfuzosin 8.3.2.1.2. Doxazosin 8.3.2.1.3. Tamsulosin 8.3.2.1.4. Silodosin 8.3.2.1.5. Other Alpha Blockers 8.3.2.2. 5 Alpha Reductase 8.3.2.2.1. Finasteride 8.3.2.2.2. Dutasteride 8.3.2.3. Others 8.3.3. Prostatitis 8.3.3.1. Prescription 8.3.3.2. Over the Counter 8.4. Market Attractiveness Analysis By Disease Indication 9. Global Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032, By Region 9.1. Introduction 9.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021 9.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. Asia Pacific 9.3.5. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032 10.1. Introduction 10.2. Pricing Analysis 10.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 10.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 10.4.1. By Country 10.4.1.1. U.S. 10.4.1.2. Canada 10.4.2. By Disease Indication 10.5. Market Attractiveness Analysis 10.5.1. By Country 10.5.2. By Disease Indication 11. Latin America Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032 11.1. Introduction 11.2. Pricing Analysis 11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 11.4.1. By Country 11.4.1.1. Brazil 11.4.1.2. Mexico 11.4.1.3. Rest of Latin America 11.4.2. By Disease Indication 11.5. Market Attractiveness Analysis 11.5.1. By Country 11.5.2. By Disease Indication 12. Europe Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 12.4.1. By Country 12.4.1.1. Germany 12.4.1.2. France 12.4.1.3. U.K. 12.4.1.4. Italy 12.4.1.5. Benelux 12.4.1.6. Nordic Countries 12.4.1.7. Rest of Europe 12.4.2. By Disease Indication 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Disease Indication 13. Asia Pacific Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 13.4.1. By Country 13.4.1.1. China 13.4.1.2. Japan 13.4.1.3. South Korea 13.4.1.4. Rest of Asia Pacific 13.4.2. By Disease Indication 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Disease Indication 14. Middle East and Africa Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 14.4.1. By Country 14.4.1.1. GCC Countries 14.4.1.2. South Africa 14.4.1.3. Turkey 14.4.1.4. Rest of Middle East and Africa 14.4.2. By Disease Indication 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Disease Indication 15. Key Countries Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032 15.1. Introduction 15.1.1. Market Value Proportion Analysis, By Key Countries 15.1.2. Global Vs. Country Growth Comparison 15.2. US Prostate Health Market Analysis 15.2.1. Value Proportion Analysis by Market Taxonomy 15.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.2.2.1. By Disease Indication 15.3. Canada Prostate Health Market Analysis 15.3.1. Value Proportion Analysis by Market Taxonomy 15.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.3.2.1. By Disease Indication 15.4. Mexico Prostate Health Market Analysis 15.4.1. Value Proportion Analysis by Market Taxonomy 15.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.4.2.1. By Disease Indication 15.5. Brazil Prostate Health Market Analysis 15.5.1. Value Proportion Analysis by Market Taxonomy 15.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.5.2.1. By Disease Indication 15.6. Germany Prostate Health Market Analysis 15.6.1. Value Proportion Analysis by Market Taxonomy 15.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.6.2.1. By Disease Indication 15.7. France Prostate Health Market Analysis 15.7.1. Value Proportion Analysis by Market Taxonomy 15.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.7.2.1. By Disease Indication 15.8. Italy Prostate Health Market Analysis 15.8.1. Value Proportion Analysis by Market Taxonomy 15.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.8.2.1. By Disease Indication 15.9. BENELUX Prostate Health Market Analysis 15.9.1. Value Proportion Analysis by Market Taxonomy 15.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.9.2.1. By Disease Indication 15.10. UK Prostate Health Market Analysis 15.10.1. Value Proportion Analysis by Market Taxonomy 15.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.10.2.1. By Disease Indication 15.11. Nordic Countries Prostate Health Market Analysis 15.11.1. Value Proportion Analysis by Market Taxonomy 15.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.11.2.1. By Disease Indication 15.12. China Prostate Health Market Analysis 15.12.1. Value Proportion Analysis by Market Taxonomy 15.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.12.2.1. By Disease Indication 15.13. Japan Prostate Health Market Analysis 15.13.1. Value Proportion Analysis by Market Taxonomy 15.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.13.2.1. By Disease Indication 15.14. South Korea Prostate Health Market Analysis 15.14.1. Value Proportion Analysis by Market Taxonomy 15.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.14.2.1. By Disease Indication 15.15. GCC Countries Prostate Health Market Analysis 15.15.1. Value Proportion Analysis by Market Taxonomy 15.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.15.2.1. By Disease Indication 15.16. South Africa Prostate Health Market Analysis 15.16.1. Value Proportion Analysis by Market Taxonomy 15.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.16.2.1. By Disease Indication 15.17. Turkey Prostate Health Market Analysis 15.17.1. Value Proportion Analysis by Market Taxonomy 15.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 15.17.2.1. By Disease Indication 15.17.3. Competition Landscape and Player Concentration in the Country 16. Market Structure Analysis 16.1. Market Analysis by Tier of Companies 16.2. Market Concentration 16.3. Market Share Analysis of Top Players 16.4. Market Presence Analysis 16.4.1. By Regional footprint of Players 16.4.2. Product footprint by Players 17. Competition Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Competition Deep Dive 17.3.1. GLAXOSMITHKLINE 17.3.1.1. Overview 17.3.1.2. Product Portfolio 17.3.1.3. Sales Footprint 17.3.1.4. Strategy Overview 17.3.2. ASTELLAS PHARMA 17.3.2.1. Overview 17.3.2.2. Product Portfolio 17.3.2.3. Sales Footprint 17.3.2.4. Strategy Overview 17.3.3. ALLERGAN 17.3.3.1. Overview 17.3.3.2. Product Portfolio 17.3.3.3. Sales Footprint 17.3.3.4. Strategy Overview 17.3.4. MERCK 17.3.4.1. Overview 17.3.4.2. Product Portfolio 17.3.4.3. Sales Footprint 17.3.4.4. Strategy Overview 17.3.5. ELI LILLY AND COMPANY 17.3.5.1. Overview 17.3.5.2. Product Portfolio 17.3.5.3. Sales Footprint 17.3.5.4. Strategy Overview 17.3.6. ABBOTT LABORATORIES 17.3.6.1. Overview 17.3.6.2. Product Portfolio 17.3.6.3. Sales Footprint 17.3.6.4. Strategy Overview 17.3.7. JOHNSON & JOHNSON SERVICES, INC. 17.3.7.1. Overview 17.3.7.2. Product Portfolio 17.3.7.3. Sales Footprint 17.3.7.4. Strategy Overview 17.3.8. ABBVIE 17.3.8.1. Overview 17.3.8.2. Product Portfolio 17.3.8.3. Sales Footprint 17.3.8.4. Strategy Overview 17.3.9. SANOFI 17.3.9.1. Overview 17.3.9.2. Product Portfolio 17.3.9.3. Sales Footprint 17.3.9.4. Strategy Overview 17.3.10. PFIZER, INC. 17.3.10.1. Overview 17.3.10.2. Product Portfolio 17.3.10.3. Sales Footprint 17.3.10.4. Strategy Overview 18. Assumptions and Acronyms Used 19. Research Methodology Table 1: Global Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021 Table 2: Global Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032 Table 3: Global Prostate Health Market, By Region, 2015 – 2021 Table 4: Global Prostate Health Market, By Region, 2022 – 2032 Table 5: North America Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021 Table 6: North America Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032 Table 7: North America Prostate Health Market, By Country, 2015 – 2021 Table 8: North America Prostate Health Market, By Country, 2022 – 2032 Table 9: Latin America Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021 Table 10: Latin America Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032 Table 11: Latin America Prostate Health Market, By Country, 2015 – 2021 Table 12: Latin America Prostate Health Market, By Country, 2022 – 2032 Table 13: Europe Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021 Table 14: Europe Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032 Table 15: Europe Prostate Health Market, By Country, 2015 – 2021 Table 16: Europe Prostate Health Market, By Country, 2022 – 2032 Table 17: Asia Pacific Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021 Table 18: Asia Pacific Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032 Table 19: Asia Pacific Prostate Health Market, By Country, 2015 – 2021 Table 20: Asia Pacific Prostate Health Market, By Country, 2022 – 2032 Table 21: MEA Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021 Table 22: MEA Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032 Table 23: MEA Prostate Health Market, By Country, 2015 – 2021 Table 24: MEA Prostate Health Market, By Country, 2022 – 2032 Table 25: Global Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021 Table 26: Global Prostate Health Market Incremental $ Opportunity, By Region, 2022 – 2032 Table 27: North America Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021 Table 28: North America Prostate Health Market Incremental $ Opportunity, By Country, 2022 – 2032 Table 29: Latin America Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021 Table 30: Latin America Prostate Health Market Incremental $ Opportunity, By Country, 2022 – 2032 Table 31: Europe Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021 Table 32: Europe Prostate Health Market Incremental $ Opportunity, By Country, 2022 - 2032 Table 33: Asia Pacific Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021 Table 34: Asia Pacific Prostate Health Market Incremental $ Opportunity, By Country, 2022 – 2032 Table 35: MEA Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021 Table 36: MEA Prostate Health Market Incremental $ Opportunity, By Country, 2022 - 2032 Figure 1: Global Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032 Figure 2: Global Prostate Health Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn Figure 3: Global Prostate Health Market Share, By Disease Indication, 2022 & 2032 Figure 4: Global Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032 Figure 5: Global Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032 Figure 6: Global Prostate Health Market Share, By Region, 2022 & 2032 Figure 7: Global Prostate Health Market Y-o-Y Growth Projections, By Region – 2022-2032 Figure 8: Global Prostate Health Market Attractiveness Index, By Region – 2022-2032 Figure 9: North America Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032 Figure 10: North America Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn Figure 11: North America Prostate Health Market Share, By Disease Indication, 2022 & 2032 Figure 12: North America Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032 Figure 13: North America Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032 Figure 14: North America Prostate Health Market Share, By Country, 2022 & 2032 Figure 15: North America Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032 Figure 16: North America Prostate Health Market Attractiveness Index, By Country – 2022-2032 Figure 17: Latin America Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032 Figure 18: Latin America Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn Figure 19: Latin America Prostate Health Market Share, By Disease Indication, 2022 & 2032 Figure 20: Latin America Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032 Figure 21: Latin America Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032 Figure 22: Latin America Prostate Health Market Share, By Country, 2022 & 2032 Figure 23: Latin America Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032 Figure 24: Latin America Prostate Health Market Attractiveness Index, By Country – 2022-2032 Figure 25: Europe Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032 Figure 26: Europe Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn Figure 27: Europe Prostate Health Market Share, By Disease Indication, 2022 & 2032 Figure 28: Europe Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032 Figure 29: Europe Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032 Figure 30: Europe Prostate Health Market Share, By Country, 2022 & 2032 Figure 31: Europe Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032 Figure 32: Europe Prostate Health Market Attractiveness Index, By Country – 2022-2032 Figure 33: MEA Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032 Figure 34: MEA Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn Figure 35: MEA Prostate Health Market Share, By Disease Indication, 2022 & 2032 Figure 36: MEA Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032 Figure 37: MEA Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032 Figure 38: MEA Prostate Health Market Share, By Country, 2022 & 2032 Figure 39: MEA Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032 Figure 40: MEA Prostate Health Market Attractiveness Index, By Country – 2022-2032 Figure 41: Asia Pacific Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032 Figure 42: Asia Pacific Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn Figure 43: Asia Pacific Prostate Health Market Share, By Disease Indication, 2022 & 2032 Figure 44: Asia Pacific Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032 Figure 45: Asia Pacific Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032 Figure 46: Asia Pacific Prostate Health Market Share, By Country, 2022 & 2032 Figure 47: Asia Pacific Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032 Figure 48: Asia Pacific Prostate Health Market Attractiveness Index, By Country – 2022-2032 Figure 49: US Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 50: US Prostate Health Market Share, By Disease Indication, 2021 Figure 51: Canada Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 52: Canada Prostate Health Market Share, By Disease Indication, 2021 Figure 53: Brazil Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 54: Brazil Prostate Health Market Share, By Disease Indication, 2021 Figure 55: Mexico Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 56: Mexico Prostate Health Market Share, By Disease Indication, 2021 Figure 57: Germany Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 58: Germany Prostate Health Market Share, By Disease Indication, 2021 Figure 59: U.K. Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 60: U.K. Prostate Health Market Share, By Disease Indication, 2021 Figure 61: France Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 62: France Prostate Health Market Share, By Disease Indication, 2021 Figure 63: Italy Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 64: Italy Prostate Health Market Share, By Disease Indication, 2021 Figure 65: BENELUX Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 66: BENELUX Prostate Health Market Share, By Disease Indication, 2021 Figure 67: Nordic Countries Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 68: Nordic Countries Prostate Health Market Share, By Disease Indication, 2021 Figure 69: China Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 70: China Prostate Health Market Share, By Disease Indication, 2021 Figure 71: Japan Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 72: Japan Prostate Health Market Share, By Disease Indication, 2021 Figure 73: South Korea Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 74: South Korea Prostate Health Market Share, By Disease Indication, 2021 Figure 75: GCC Countries Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 76: GCC Countries Prostate Health Market Share, By Disease Indication, 2021 Figure 77: South Africa Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 78: South Africa Prostate Health Market Share, By Disease Indication, 2021 Figure 79: Turkey Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032 Figure 80: Turkey Prostate Health Market Share, By Disease Indication, 2021
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
Future Market Insights社の分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問Future Market Insights社はどのような調査会社ですか?Future Market Insights(FMI)は世界の広範な地域および産業を対象にした調査レポートを出版しています。 弊社ウェブサイトに掲載のないタイトルも全てお取り扱い可能ですので... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2025/05/02 10:26 146.99 円 166.15 円 197.83 円 |